| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.0M | — |
| R&D Expense | $11.3M | +29.3% |
| SG&A Expense | $11.4M | +53.7% |
| Operating Income | -$22.7M | -40.5% |
| Pre-tax Income | -$21.7M | -39.1% |
| Income Tax | $41K | +55.4% |
| Net Income | -$21.6M | -40.1% |
| EPS (Basic) | -$0.76 | +14.6% |
| EPS (Diluted) | -$0.76 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.7M | +1.0% |
| Current Assets | $20.2M | +2.1% |
| Total Assets | $22.9M | +15.2% |
| Current Liabilities | $8.7M | +133.4% |
| Total Liabilities | $9.7M | +160.5% |
| Stockholders' Equity | $13.3M | -19.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.6M | -28.3% |
| Capital Expenditures | $1.2M | +2160.9% |
| Investing Cash Flow | -$1.2M | -2160.9% |
| Financing Cash Flow | $15.9M | +3.1% |
| Free Cash Flow | -$15.8M | -38.1% |
| +14.6% |